Where does Adelphi Technology, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Adelphi Technology, Inc. ranks #23,779 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Adelphi Technology, Inc. hold?

Adelphi Technology, Inc. holds 11 US utility patents granted between 2017 and 2023, spanning 6 technology areas.

What is Adelphi Technology, Inc.'s Innovation Score?

Adelphi Technology, Inc. has an Innovation Score of 22.8 out of 100 (11th percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Adelphi Technology, Inc. focus on?

Adelphi Technology, Inc.'s top technology area is A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy) with 9 patents, ranking #407 of 1,943 assignees active in that subclass. Grants appear in 6 CPC subclasses total.

Is Adelphi Technology, Inc.'s patent grant rate increasing or decreasing?

Adelphi Technology, Inc.'s recent grant velocity is +900% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for Adelphi Technology, Inc.'s patents?

Adelphi Technology, Inc.'s patents average 8.0 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Adelphi Technology, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Adelphi Technology, Inc.

USPTO PatentsView assignee record - 11 granted patents across 6 technology areas, recorded in grant years 2017–2023. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Adelphi ranks #23,779 of 49,997 tracked US assignees by granted-patent volume, with 11 patents across 6 technology areas.

#23,779
of 49,997 US assignees by volume: 11th percentile
by Innovation Score (22.8/100): 8.0
avg claims per patent: +900%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R23779 · US Corporation #23,779 · 11 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-PAR · TYPE-USCORP · VEL-SURGE · BOOK-FULL

GRANTS-MICRO 11 grants
MID-PACK #23,779/49,997
PHOTO-FINISH Adagene
CPC-NARROW A61N · 6 areas
INNOV-THIN 22.8/100
CLAIMS-PAR 8.0 claims/avg
TYPE-USCORP US Corporation
VEL-SURGE +900% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Adagene Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Adelphi’s 22.8 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 8.6 pts (38%) Velocity 0.7 pts (3%) Breadth 8.7 pts (38%) Claim depth 4.8 pts (21%)

Qualcomm Incorporated · highest

85
Adelphi Technology · this assignee

23
3D Lighting… · lowest

7

What this shows Adelphi's Innovation Score is 22.8/100 (11th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Adelphi?

Each dot is one of Adelphi’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Adelphi’s own 8.0 claims/patent is at or below the 13.2 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Adelphi vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Adelphi's grants concentrate

Adelphi Technology, Inc. is a focused PatentsView assignee: 6 CPC subclasses with 81.8% of grants classified under A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy). Peak complete grant year is 2020 (7 grants) versus a trough of 1 in 2017. By volume, Adelphi sits between Adagene Inc. and Advanced Functional Fabrics of America, Inc..

Adelphi's three-year grant acceleration

Adelphi Technology, Inc. shows 1 grants in 2022–2024 against only 9 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Adagene

11
Adam Hall

11
Adamas Pharma

11
Adaptive 3D

11
Aditazz

11
Admar Internation…

11
Advanced Distribu…

11
Advanced Function…

11
Adelphi Technology ◀

11

What this shows Adelphi holds 11 patents at rank #23,871, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Adelphi

By rank, the assignees closest to #23,871 in granted patent volume.

Leaders in A61N (Electrotherapy)

Other assignees with the most granted patents in Adelphi's primary technology class.

Adelphi's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

23 11th percentile higher than 11% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2017–2023

Grants by year

Teal-shaded recent years (2020–present) versus the 2017–2019 baseline. Full figures in the table below.

View data table

Adelphi Technology, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2017	1	9.1%
2020	7	63.6%
2021	2	18.2%
2023	1	9.1%

Which technologies does Adelphi Technology, Inc. patent most?

A61N - ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy 9

G21G - Conversion OF Chemical ELEMENTS; Radioactive Sources 8

G21K - Techniques FOR Handling Particles OR Ionising Radiation NOT Otherwise Provided FOR; Irradiation DEVICES; Gamma RAY OR X-ray Microscopes 1

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 1

H05H - Plasma Technique ; Production OF Accelerated Electrically-charged Particles OR OF NEUTRONS; Production OR Acceleration OF Neutral Molecular OR Atomic Beams 1

H01J - Electric Discharge Tubes OR Discharge Lamps 1

Top 6 of 6 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Adelphi Technology, Inc.'s patent record in context - here's where to go next.

Adelphi Technology, Inc.'s lead technology class is A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy), 81.8% of its portfolio - see every assignee active in that class. Explore A61N
Ranked #23,779 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Adelphi Technology, Inc. against Adagene Inc., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 22.8/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent , US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.